Stocks
Funds
Screener
Sectors
Watchlists
CYRX

CYRX - CryoPort Inc Stock Price, Fair Value and News

$9.80-0.43 (-4.20%)
Market Closed

62/100

CYRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

62/100

CYRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$11.54

Target 3M

$10.67

Target 6M

$10.95

CYRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CYRX Price Action

Last 7 days

-10.7%

Last 30 days

2.6%

Last 90 days

8.9%

Trailing 12 Months

21.9%

CYRX RSI Chart

CYRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CYRX Valuation

Market Cap

490.7M

Price/Earnings (Trailing)

7.26

Price/Sales (Trailing)

2.01

EV/EBITDA

-19.74

Price/Free Cashflow

-15.74

CYRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$11.54

Target 3M

$10.67

Target 6M

$10.95

CYRX Fundamentals

CYRX Revenue

Revenue (TTM)

243.8M

Rev. Growth (Yr)

15.44%

Rev. Growth (Qtr)

-2.69%

CYRX Earnings

Earnings (TTM)

67.6M

Earnings Growth (Yr)

-962.48%

Earnings Growth (Qtr)

-106.6%

CYRX Profitability

Operating Margin

45.45%

EBT Margin

-21.95%

Return on Equity

13.17%

Return on Assets

8.73%

Free Cashflow Yield

-6.35%

CYRX Investor Care

Shares Dilution (1Y)

1.29%

Diluted EPS (TTM)

1.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025232.1M237.9M243.8M0
2024207.7M190.4M172.6M228.4M
2023247.8M240.7M236.4M233.3M
2022221.6M229.6M233.4M237.3M
2021122.2M169.0M214.5M222.6M
202037.1M38.0M39.6M78.7M
201922.3M26.1M30.4M33.9M
201813.3M15.0M17.3M19.6M
20178.8M9.8M10.9M12.0M
20165.9M6.4M6.9M7.7M
20154.3M4.8M5.4M5.9M
20142.7M3.1M3.4M3.6M
20131.1M1.4M1.7M2.2M
2012555.6K622.9K746.2K908.9K
2011475.5K447.8K434.1K478.8K
2010000386.1K
CYRX
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
 CEO
 WEBSITEcryoport.com
 SECTORIndustrials
 INDUSTRYIntegrated Freight & Logistics
 EMPLOYEES1000

CryoPort Inc Frequently Asked Questions


CYRX is the stock ticker symbol of CryoPort Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of CryoPort Inc is 490.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CYRX's fair value in chart for subscribers.

The fair value guage provides a quick view whether CYRX is over valued or under valued. Whether CryoPort Inc is cheap or expensive depends on the assumptions which impact CryoPort Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CYRX.

As of Wed Jan 28 2026, CYRX's PE ratio (Price to Earnings) is 7.26 and Price to Sales (PS) ratio is 2.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CYRX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, CryoPort Inc has provided 0.192 (multiply by 100 for percentage) rate of return.